NACL Industries (524709) Q1 26/27 earnings summary

Executive summary

• Board approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

• Board approved the sale of entire equity stake in Nasense Labs Private Limited for ₹8.15 crore.

• Post-transaction, Nasense Labs will cease to be an associate company.

Financial highlights

• Standalone revenue from operations for Q1 FY27 was ₹38,225 lakhs, down from ₹44,077 lakhs in Q1 FY26.

• Standalone net profit after tax for Q1 FY27 was ₹2,357 lakhs, up from ₹1,430 lakhs in Q1 FY26.

• Consolidated revenue from operations for Q1 FY27 was ₹38,333 lakhs, down from ₹44,953 lakhs in Q1 FY26.

• Consolidated net profit after tax for Q1 FY27 was ₹2,084 lakhs, up from ₹1,304 lakhs in Q1 FY26.

• Basic and diluted EPS for Q1 FY27 were ₹1.01 (standalone) and ₹0.89 (consolidated).

Outlook and guidance

• Board and management confirmed continued focus on core farm inputs business.

• Rights issue proceeds have been largely utilized for debt repayment and general corporate purposes.